company

NORSK DIABETESSENTER FOR BEHANDLING OG OPPLÆRING

0284 OSLO

Return on Equity
−4,7 %
Current Ratio
4,98
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue12 878 000
Net Income−615 000
Total Assets15 117 000
Total Equity13 090 000
Income (NOK)2022
Revenue12 878 000
Expenditure12 379 000
Operating Profit499 000
Financial Income1 000
Financial Costs1 114 000
Financial Balance−1 113 000
Earnings Before Tax−615 000
Tax0
Net Income−615 000
Balance (NOK)2022
Total Fixed Assets5 018 000
Total Current Assets10 099 000
Total Assets15 117 000
Total Retained Equity11 626 000
Total Equity13 090 000
Total Long-Term Debt0
Total Current Debt2 027 000
Total Equity and Debt15 117 000
Cash flow (NOK)2022
Sales Income12 492 000
Other Income386 000
Revenue12 878 000
Cost of Goods Sold303 000
Salary Costs10 338 000
Depreciation163 000
Impairment0
Expenditure12 379 000
Operating Profit499 000
Financial Income1 000
Financial Costs1 114 000
Financial Balance−1 113 000
Dividends0
Net Income−615 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate4 725 000
Machinery and Plant Facilities0
Fixtures159 000
Total Tangible Assets4 884 000
Total Fiancial Fixed Assets134 000
Total Fixed Assets5 018 000
Stock0
Total Investments8 252 000
Cash, Bank1 609 000
Total Current Assets10 099 000
Total Assets15 117 000
Total Equity13 090 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors70 000
Unpaid Taxes776 000
Dividends0
Other Current Debt1 181 000
Total Current Debt2 027 000
Total Equity and Debt15 117 000
Financial indicators2022
Return on Equity−4,7 %
Debt-to-Equity Ratio0
Operating Profit Margin3,87 %
Current Ratio4,98
Quick Ratio4,98
Equity Ratio0,87
Gross Profit Margin97,65 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English